Cortexyme announces change in executive leadership team

South san francisco, calif.--(business wire)---- $crtx--cortexyme, inc. (nasdaq: crtx), a clinical-stage biopharmaceutical company focused on alzheimer's and other degenerative diseases, today announced that its board of directors has appointed christopher lowe, the company's chief operating officer and chief financial officer, as interim chief executive officer, effective immediately. this appointment follows the departure of casey lynch as the company's chief executive officer and chair of the board. c
QNCX Ratings Summary
QNCX Quant Ranking